This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Cosmo Technologies Limited, Cosmo Bio-Technologies Srl. Active years: 2014-2024.
Company Filing History:
Years Active: 2014-2024
Title: The Innovative Contributions of Mara Gerloni
Introduction
Mara Gerloni is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of seven patents to her name, her work has the potential to impact cancer treatment significantly.
Latest Patents
One of her latest patents involves the use of 17α-monoesters and 17α,21-diesters of cortexolone for the treatment of tumors. This invention relates to specific cortexolone derivatives that serve as antitumor active ingredients. These derivatives are intended for use in curative, adjuvant, neoadjuvant, or palliative treatments of precancerous lesions, dysplasias, metaplasias, and various tumor diseases, including malignant neoplasias and metastasis. Additionally, the patent includes pharmaceutical compositions that comprise these cortexolone derivatives as active ingredients, along with at least one physiologically acceptable excipient, aimed at being effective antitumor medicinal products.
Career Highlights
Throughout her career, Mara Gerloni has worked with notable companies in the biotechnology sector. She has been associated with Cosmo Technologies Limited and Cosmo Bio-technologies Srl, where she has contributed her expertise in developing innovative pharmaceutical solutions.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Mara Gerloni's innovative work in the field of pharmaceuticals, particularly her patents related to cortexolone derivatives, showcases her commitment to advancing cancer treatment. Her contributions are poised to make a significant difference in the lives of patients battling tumor-related diseases.